Home > Riviste > Minerva Pediatrica > Fascicoli precedenti > Minerva Pediatrica 2018 October;70(5) > Minerva Pediatrica 2018 October;70(5):488-92

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

REVIEW   

Minerva Pediatrica 2018 October;70(5):488-92

DOI: 10.23736/S0026-4946.17.04781-8

Copyright © 2017 EDIZIONI MINERVA MEDICA

lingua: Inglese

High-flow nasal cannula therapies for respiratory management in pediatric patients

Gang LIU, Conghai FAN , Hongwei WU

Department of Neonatology, Xuzhou Children’s Hospital, Xuzhou, China



High-flow nasal cannula (HFNC) oxygen therapy is a non-invasive form of respiratory support that is rapidly being taken up in pediatric intensive care units (PICU). For infants with bronchiolitis, who are the largest non-elective source of admissions to a PICU, there is some evidence that using HFNC therapy reduces the need for intubation and mechanical ventilation. The aim of this review article is to explore, describe, critique and add to the evidence surrounding the use of HFNC therapy in the pediatric population for the management of respiratory distress.


KEY WORDS: Cannula - Airway management - Pediatrics - Bronchiolitis - Respiration disorders

inizio pagina